Marianne Abifadel

Inserm — France

Medicine · Health Sciences

34h-index8.5kcitations101works2.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lipoproteins and Cardiovascular Health(66), Cancer, Lipids, and Metabolism(22), Diabetes, Cardiovascular Risks, and Lipoproteins(15), Lipid metabolism and disorders(12), Cholesterol and Lipid Metabolism(8)

Publications101 total

Microbiota-derived short-chain fatty acids in hematopoietic stem cell transplantation: immunomodulation at the host-microbiota interface
Frontiers in Microbiology·2026Open Access
A New Breath: Dynamics of Respiratory Infections After the Lifting of Non-Pharmaceutical Interventions Related to COVID-19
Microorganisms·2025Open Access
Gut microbiota and viral respiratory infections: microbial alterations, immune modulation, and impact on disease severity: a narrative review
Frontiers in Microbiology·2025· 6 citedOpen Access
An insight into the characterization of L2 Beijing multi-drug resistant tuberculosis: Description of resistance-associated-variants and discovery of Modern 7 L2 sublineage
Infection Genetics and Evolution·2025Open Access
Upregulation of the maresin pathway and PGE2 metabolism in the failing human left ventricle
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids·2025· 1 cited
PCSK9 in Familial Hypercholesterolemia and Beyond
JAMA Cardiology·2025
Clustering and visualisation of the GABRIEL network expertise in the field of infectious diseases
BMJ Global Health·2025Open Access
Scientific journey from PSCK9 discovery in familial hypercholesterolaemia
Nature Reviews Cardiology·2025· 2 cited
Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registry
European Heart Journal·2025· 13 citedOpen Access
SMASH: An initiative for equitable access to precision medicine for rare or severe lipid disorders
European Atherosclerosis Journal·2024· 1 citedOpen Access
FIRST REPORTED APOA5 VARIANT IN LEBANON CAUSING HYPERCHYLOMICRONEMIA SYNDROME
Atherosclerosis·2024
ROLE OF PATIENT ADVOCATES IN SECURING APHERESIS ACCESS IN LEBANON
Atherosclerosis·2024
THE MOLECULAR BASIS OF DIFFERENT GENETIC LIPID DISORDERS IN LEBANON
Atherosclerosis·2024
Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study
The Lancet Diabetes & Endocrinology·2024· 10 citedOpen Access
The singular French PCSK9-p.Ser127Arg gain-of-function variant: A significant player in cholesterol levels from a 775-year-old common ancestor
Atherosclerosis·2024Open Access
Characteristics of Hospitalized COVID-19 Patients at Admission and Factors Associated with Clinical Severity in Low- and Middle-Income Countries: An Observational Study
American Journal of Tropical Medicine and Hygiene·2024· 2 citedOpen Access
Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study
The Lancet·2023· 71 citedOpen Access
Effect of Mediterranean Dietary Pattern on Cognitive Status in Community-Dwelling Older Adults
Nutrients·2023Open Access
Identification of the specific molecular and functional signatures of pre-beta-HDL: relevance to cardiovascular disease
Basic Research in Cardiology·2023· 14 cited
Involvement of U2-spliceosome in autosomal dominant hypercholesterolemia
Atherosclerosis·2023Open Access
page 1 of 6Next →

Frequent Co-authors

Cathérine Boileau(37), Mathilde Varret(33), Jean‐Pierre Rabès(24), Éric Bruckert(11), Claudine Junien(9), Nabil G. Seidah(8), Khalid Al‐Rasadi(8), Mafalda Bourbon(8), Petra El Khoury(8), Delphine Allard(7), Martine Devillers(7), Tomáš Freiberger(7), Mariko Harada‐Shiba(7), Heribert Schunkert(7), Sandy Elbitar(7), Youmna Ghaleb(7), D. Erlich(6), Antonio J. Vallejo‐Vaz(6), G. Kees Hovingh(6), Pedro Mata(6)